Both in Pharmaceuticals
BridgeBio Pharma vs Summit Therapeutics
Over the past year BBIO returned +27.0% and SMMT returned −22.5%; their daily moves had a correlation of 0.32.
BBIO +27.0% SMMT −22.5%Growth of $1, one year, split-adjusted
| Metric | BBIO | SMMT |
|---|---|---|
| Price | $65.97 | $16.39 |
| Market cap | $12.90B | $13.08B |
| Today | −0.96% | +5.88% |
| 1 month | −13.9% | +19.4% |
| 6 months | −4.9% | −3.5% |
| Year to date | −13.8% | −6.3% |
| 1 year | +31.8% | −21.8% |
| Revenue growth (YoY) | +120.4% | — |
| Gross margin | 93.8% | — |
| Net margin | −62.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 18.1× | — |
| Net cash | -$1.76B | $690.7M |
| Dividend yield | — | — |
| Volatility (60d) | 42.8% | 69.5% |
| Short % of float | 13.4% | 29.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).